Dennis Podlesak Syndax Pharmaceuticals Inc (SNDX) insider trading activity

Dennis Podlesak is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 191,763 shares of SNDX, which is worth approximately $3.04 Million. The most recent transaction as insider was on Aug 18, 2025, when has been sold 19,200 shares (Common Stock) at a price of $15.84 per share, resulting in proceeds of $304,128. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 192K

0% 3M change

35.27% 12M change

Total Value Held $3.04 Million

Dennis Podlesak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 18 2025	SELL Open market or private sale	$304,128 $15.84 p/Share	19,200 Reduced 9.1%	191,763 Common Stock
Aug 18 2025	BUY Exercise of conversion of derivative security	$138,240 $7.2 p/Share	19,200 Added 8.34%	210,963 Common Stock
Aug 15 2025	SELL Open market or private sale	$298,368 $15.54 p/Share	19,200 Reduced 9.1%	191,763 Common Stock
Aug 15 2025	BUY Exercise of conversion of derivative security	$138,240 $7.2 p/Share	19,200 Added 8.34%	210,963 Common Stock
Aug 14 2025	SELL Open market or private sale	$272,448 $14.19 p/Share	19,200 Reduced 9.1%	191,763 Common Stock
Aug 14 2025	BUY Exercise of conversion of derivative security	$138,240 $7.2 p/Share	19,200 Added 8.34%	210,963 Common Stock
Feb 05 2025	BUY Grant, award, or other acquisition	-	50,000 Added 20.68%	191,763 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	34,000 Added 19.34%	141,763 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	32,000 Added 22.9%	107,763 Common Stock
Sep 16 2022	SELL Open market or private sale	$280,574 $23.43 p/Share	11,975 Reduced 13.65%	75,763 Common Stock
Sep 16 2022	BUY Exercise of conversion of derivative security	$75,922 $6.34 p/Share	11,975 Added 12.7%	82,319 Common Stock
Sep 15 2022	SELL Open market or private sale	$1,617,528 $24.2 p/Share	66,840 Reduced 46.87%	75,763 Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$422,429 $6.32 p/Share	66,840 Added 31.91%	142,603 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	32,000 Added 29.69%	75,763 Common Stock
Oct 05 2021	BUY Other acquisition or disposition	-	463 Added 1.05%	43,763 Common Stock
Apr 22 2021	BUY Open market or private purchase	$197,074 $14.11 p/Share	13,967 Added 24.39%	43,300 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	29,333 Added 50.0%	29,333 Common Stock

Dennis Podlesak

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Value

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX

Account